By Steve Kirsch
Pfizer’s Phase 3 clinical trials for its Covid-19 vaccine are riddled with holes, but Pfizer is not being investigated.
There are more than a dozen “smoking guns” that indicate that the Pfizer Phase 3 trial was not properly conducted. The FDA should investigate all these allegations, but they aren’t. Why not?
It is in the best interest of all parties to have transparency in these issues in order to restore public trust in the medical community and reduce vaccine hesitancy which are key goals of the CDC and FDA.
For example, Dr. Peter Marks recently stated:
“We do have a problem with vaccine uptake that is very serious in the United States and anything we can do to get people more comfortable to be able to accept these potentially life-saving medical products is something that we feel we are compelled to do,” said Dr. Peter Marks, director of the Center for Biologics Evaluation and Research.
There are two things Dr. Marks can do to achieve his goal:
- He can have an open discussion with the people who he alleges are the main spreaders of “misinformation.”
- He can open an official FDA investigation into allegations of fraud in the Pfizer trial and produce a written report responding to each allegation.
Dr. Marks, like every other public health official, will not do #1. I understand why he won’t: the data isn’t supportive of the government narrative so he’d lose the debate very badly. This is why nobody at the FDA, CDC, or NIH will talk to any of my colleagues. In ignoring us, he is acting in a way inconsistent with what is expected which was outlined by UCSF Professor Vinay Prasad in this op-ed published 2 years ago, Scientists who express different views on Covid-19 should be heard, not demonized
The views and opinions expressed in this commentary are those of the author and do not reflect the official position of Citizens Journal